Company: Art4Love, Inc.
OTC Symbol: ALVN.PK
A4L GALLERY Continues Its International Presence in the New York Art Scene .
NEW YORK, Feb. 22 /PRNewswire-FirstCall/ - Art4Love Inc. (ALVN.PK), announces that their A4L GALLERY continues to internationalize and revitalize the New York Art Scene by including outstanding European artists in its monthly gallery shows. Each month A4L GALLERY devotes exhibit art space for one of its 1200 members from 30+ countries worldwide.
A4L GALLERY's unique mission is to bring global creative influence to the New York art world, positioning Art4Love as an international force. "In our inaugural year alone at A4L GALLERY four of the eleven artists showing are not American. Next year we plan to make it fifty percent international artists, and grow it from there, as needed," said Chad Love Lieberman, CEO of Art4Love, Inc., the parent of A4L Gallery.
To bolster in international efforts A4L GALLERY has also joined ARTNET, the world's largest database of galleries and fine art. ARTNET is the largest online gallery network of its kind, with over 1,000 galleries in 250 international cities, more than 150,000 works by over 25,000 artists from around the globe. "We are extremely happy to be part of this ARTNET's on-line network," noted Lieberman. "This positions Art4Love and A4L GALLERY among the leading galleries in the world, giving us additional exposure for our art collection and our artists. It further positions Art4Love as an international presence in the art world and delivers on our commitment to our member artists to provide world-class representation," concluded Lieberman.
About A4L GALLERY:
Located in East Chelsea at 45 East 20th Street, 9th floor New York, NY, A4L GALLERY exhibits the works of its member artists from the United States and 33 other countries. Gallery hours are Tuesday through Saturday, 10 AM to 6 PM. For more information, visit the site at http://www.a4lgallery.com.
About Art4Love:
Art4Love Inc. (ALVN) is an emerging growth art company with access to the works of 1,200 artists, representing the rights of over 15,000 pieces of original artwork by both established and emerging artists worldwide. Offering a comprehensive range of leasing and sales options and an extensive selection of artwork, the Company provides a "one-stop/full-service environment" to assist its corporate clients with all facets of their art needs. For further information on Art4Love Inc. visit the website at http://www.art4love.com.
DISCLAIMER:
Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements. "Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur. As with many microcaps, today's featured company has factors that raise substantial doubt about its ability to continue as a going concern. Furthermore, the company has a large accumulated deficit since its inception and a substantial negative net worth. An investment in today's featured company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. OTC Vault advises all readers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice or solicitation. The publisher of OTC Vault is not a registered investment advisor. Subscribers should not view information herein as legal, tax, accounting or investment advice. All information within this email is qualified in its entirety by the detailed information and financial statements of the featured company contained in its regulatory filings with the SEC. End-Users are responsible for verifying all claims and conducting their own due diligence. Any reference to past performance of companies are specially selected to be referenced based on the favorable performance of these companies. You would need perfect timing to achieve the results in the examples given. There can be no assurance of that happening. Remember, as always, past performance is never indicative of future results and a thorough due diligence effort, including a review of a company's filings, should be completed prior to investing. Past performance is never indicative of future results. This email message may contain references or links to web sites operated by third parties. Such references or links are provided for the reader's reference and convenience only. We are not responsible for the reliability of these external sites nor are we responsible for any of the contents, advertising, products, or other materials on such external sites. Our inclusion of references or links to such web sites does not imply any endorsement of the material on such web sites or any association with their operators. Under no circumstances shall we be held responsible or liable, directly or indirectly, for any loss or damage caused or alleged to have been caused in connection with the use of or reliance on any content, goods, or services available on such external site. In compliance with the Securities Act of 1933, Section17(b), OTC Vault has received forty-eight thousand dollars from a third party not an officer, director or affiliate shareholder for the publication of this report. Be aware of an inherent conflict of interest resulting from such compensation due to our intent to profit from the liquidation of these shares. All factual information in this report was gathered from public sources, including but not limited to SEC filings and Company Press Releases and provided to OTC Vault by a third party not an officer, director or affiliate shareholder. OTCVault believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. All information provided regarding the companies featured on this web site comes from the companies themselves, SEC filings, news releases, company web sites as well as other sources of publicly available information. The profiles of companies are not a solicitation or recommendation to buy, sell, or hold these or any other securities.